[1] van-der-Bogt KE, Schrepfer S, Yu J, Sheikh AY, Hoyt G, Govaert JA, Velotta JB, Contag CH, Robbins RC, Wu JC. Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. [J]. Transplantation: Official Journal of the Transplantation Society 2009, 5(5).
[2] VAN LAAR J M, TYNDALL A. Cellular therapy of systemic sclerosis [J]. Current Rheumatology Reports 2008, 10(03).
[3] Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani Ingoni R, Campbell C, Memon S, Nagle JW, Hakim FT, Gress RE, McFarland HF, Burt RK, Martin R. [J]. The Journal of Experimental Medicine 2005.
[4] Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R, Hiepe F, Lisukov I, Musso M, Ou Yang J, Marsh J, Wulffraat N, Besalduch J, Bingham SJ, Emery P, Brune M, Fassas A, Faulkner L, Ferster A, Fiehn C, Fouillard L, Geromin A, Greinix H, Rabusin M, Saccardi R, Schneider P, Zintl F, Gratwohl A, Tyndall A. Autologous stem cell transplantation for systemic lupus erythematosus. [J]. Lupus 2004, 3(3).
[5] ORLIC D, KAJSTURA J, CHIMENTI S. Bone marrow cells regenerate infarcted myocardium [J]. Nature 2001, 410(6829).
[6] BELTRAMI A P, BARLUCCHI L, TORELLA D. Adult cardiac stem cells are multipotent and support myocardial regeneration [J]. Cell 2003, 114(06).
[7] TOMA C, PITTENCER M F, CAHILL K S. Human mesenc.hymal stem cells diferentiate to a cardiomyocyte phenotype in the adult murine beart [J]. Circulation 2002, 105(01).
[8] Steingen C, Brenig F, Baumgartner L, Schmidt J, Schmidt A, Bloch W. Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. [J]. Journal of Molecular and Cellular Cardiology 2008, 6(6).
[9] Langer HF, Stellos K, Steingen C. Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. [J]. Journal of Molecular and Cellular Cardiology 2009, 2(2).
[10] Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. [J]. The Lancet 2003, 9385(9385).
[11] Dai Y, Xu M, Wang Y, Pasha Z, Li T, Ashraf M. [J]. Journal of Molecular and Cellular Cardiology 2007.
[12] YANG Zhijian, MA Dongchao, WANC Wei. Experimental study of hone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction [J]. Gene Therapy 2006, 13(22).
[13] Aupperle H, Garbade J, Schubert A, Barten M, Dhein S, Schoon HA, Mohr FW. Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in Doxorubicin cardiomyopathy in a rabbit model [J]. Veterinary pathology 2007, 4(4).
[14] Aldinucci A, Rizzetto L, Pieri L, Nosi D, Romagnoli P, Biagioli T, Mazzanti B, Saccardi R, Beltrame L, Massacesi L, Cavalieri D, Ballerini C. Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation. [J]. The Journal of Immunology: Official Journal of the American Association of Immunologists 2010, 9(9).
[15] Stroncek, D, Berlyne, D, Fox, B, Gee, A, Heimfeld, S, Lindblad, R, Loper, K, Mckenna, D, Rooney, C, Sabatino, M, Wagner, E, Whiteside, T, Wood, D, Heath-Mondoro, T. Developments in clinical cell therapy [J]. Cytotherapy 2010, 3(3).
[16] Atoui R, Shum-Tim D, Chiu RC. Myocardial regenerative therapy: immunologic basis for the potential universal donor cells. [J]. The Annals of Thoracic Surgery: Official Journal of the Society of Thoracic Surgeons and the Southern Thoracic Surgical Association 2008, 1(1).
[17] Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. [J]. The New England journal of medicine 2006, 12(12).
[18] van Ramshorst J, Bax JJ, Beeres SL, Dibbets Schneider P, Roes SD, Stokkel MP, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ, Atsma DE. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. [J]. JAMA: the Journal of the American Medical Association 2009, 19(19).
[19] Hare JM, Traverse JH, Henry T. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. [J]. Journal of the American College of Cardiology 2009, 24(24).
[20] CHEN Shaoliang, WU Wangfang, YE Fei. Effect on left ventricular function ofintracoronary transplantation of autologous bone marrow mesenchymastem cellin patients with acute myocardialinfarction [J]. American Journal of Cardiology 2004, 94(01). |
